Areas of expertise:
Dr. Bahler's clinical interests are minimally invasive surgical treatment approaches for prostate cancer and kidney cancer as well as the treatment of kidney stone disease.
Dr. Clint Bahler's research is focused on minimally invasive treatments for prostate and kidney cancer. Dr. Bahler is the principle investigator on a trial to preserve renal function during partial nephrectomy for small renal masses (NCT02131376).
Dr. Bahler is also involved in research efforts to better detect prostate cancer using PSMA-PET imaging for a more complete resection at the time of surgery as well as research involving MRI-fusion biopsy of the prostate and HIFU (High Intensity Focused Ultrasound) treatment of the prostate.
His areas of clinical interest are prostate cancer and kidney cancer.
My clinical and research interests are in prostate and kidney cancer. My early work has been in predicting renal function loss during the surgical removal of small renal masses from kidneys. We have an IU-Health Values grant and are conducting a RCT. I'm also interested in targeted imaging and have a CTSI-CTR grant to collaborate with Purdue University for intra-operative real time kidney cancer detection. I also work with large databases such as NIS (Nationwide Inpatient Sample) and NCDB (National Cancer Database) on outcomes related projects and am able to perform my own statistical analyses using STATA.
